Rite Aid Expands COVID-19 On-site Testing: 24 Locations Now Open Across Eight States
20 April 2020 - 04:00PM
Business Wire
Additional Self-Swab Drive-Through Tests Now
Available in Delaware, Idaho, Michigan, New York, New Jersey, Ohio,
Pennsylvania, and Virginia
Rite Aid (NYSE: RAD) continues to expand COVID-19 testing sites
with eleven new locations opening Wednesday, April 22, in Delaware,
Idaho, Michigan, New York, New Jersey, Ohio, Pennsylvania, and
Virginia through its partnership with the U.S. Department of Health
and Human Services (HHS).
Now spanning eight states and 24 store locations, all of Rite
Aid’s self-testing sites will be open from 9 a.m.-5 p.m. seven days
a week and expect to be able to conduct approximately 200 tests
each day through online appointments. In total, Rite Aid will have
the capacity to conduct nearly 5,000 tests daily across all
locations.
New Rite Aid COVID-19 self-swab testing site locations opening
Wednesday, April 22:
- Dover, DE: 200 Pharmacy Drive in Smyrna
- Boise, ID: 3250 S. Eagle Road in Meridian
- Grand Rapids, MI: 5995 Kalamazoo Avenue, SE in
Kentwood
- Saginaw, MI: 4598 State Street in Saginaw
- Central, NJ: 31 Mule Road in Toms River
- Albany, NY: 1863 Central Avenue in Colonie
- Akron, OH: 4053 South Main Street in Akron
- Youngstown, OH: 713 North State Street in Girard
- Erie, PA: 5430 Peach Street in Erie
- Scranton, PA: 20 South River Street in Plains
- Virginia Beach, VA: 2293 Upton Drive in Virginia
Beach
All Rite Aid drive-up COVID-19 testing locations will utilize
self-swab nasal tests overseen by Rite Aid pharmacists. Testing
eligibility is based on guidelines established by the Centers for
Disease Control and Prevention (CDC), which can be found here.
The testing will take place in each store’s parking lot. As part
of the testing process, people must remain in their vehicles from
the time they arrive and until they depart.
Testing will be available at no cost to eligible individuals who
meet criteria established by the CDC. Patients are required to
provide government issued identification, be at least 18 years old
and need to pre-register online at www.riteaid.com in order to
schedule a time slot for testing.
Rite Aid has partnered with Verily and will use its Baseline
COVID-19 Program to provide screening, scheduling and return of
results to participants for Rite-Aid testing sites.
Rite Aid also selected BioReference Laboratories to provide
COVID-19 laboratory testing to all drive-up locations with the goal
of flattening the curve through accessible diagnostic testing.
Clinical oversight for the COVID-19 testing program is provided
by PWNHealth, a national clinician network that enables safe and
easy access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company’s progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 18
states. Through EnvisionRxOptions, we provide pharmacy benefits and
services to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200420005227/en/
MEDIA: Christopher Savarese (717) 975-5718
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Mär 2023 bis Mär 2024